IKBKAP rs111033171: What Your Genotype Means

What each genotype means

Understanding the Variant and Its Location

The variant rs111033171 is a single nucleotide polymorphism (SNP) located on chromosome 9. In scientific literature, it is frequently identified by its legacy nomenclature, such as IVS20+6T>C or c.2204+6T>C. This specific change occurs within the IKBKAP gene, which encodes the ELP1 protein. The mutation is located at a donor splice site, which is a critical region for the proper processing of genetic instructions. When this specific nucleotide change occurs, it disrupts the normal splicing process, often leading to the skipping of exon 20 during the creation of messenger RNA. This disruption prevents the cell from producing functional ELP1 protein, which is essential for the development and survival of certain nerve cells. Because this variant is well-documented in genomic databases, it serves as a key marker for clinical screening programs focused on identifying carrier status for specific inherited conditions.

The Role of the IKBKAP Gene

The IKBKAP gene, also known as ELP1, provides the instructions for making a protein called the elongator acetyltransferase complex subunit 1. This protein is a vital component of the Elongator complex, which plays a significant role in various cellular processes, including the regulation of gene expression and the modification of proteins. Most importantly, the ELP1 protein is crucial for the normal development and function of the autonomic and sensory nervous systems. The autonomic nervous system controls involuntary bodily functions such as blood pressure, heart rate, and digestion, while the sensory nervous system is responsible for processing pain and temperature sensations. When mutations like rs111033171 prevent the production of functional ELP1, the resulting deficiency leads to the clinical features observed in familial dysautonomia. This condition, also known as Riley-Day syndrome, is characterized by a reduced ability to feel pain and temperature, as well as significant cardiovascular and gastrointestinal instability.

Research and Clinical Associations

Research has established a very strong association between the rs111033171 variant and familial dysautonomia. Studies have consistently shown that this specific intronic mutation accounts for more than 99% of the disease-causing alleles found in Ashkenazi Jewish individuals affected by the condition. Because familial dysautonomia is an autosomal recessive disorder, an individual must inherit two copies of a pathogenic variant—one from each parent—to manifest the symptoms of the disease. The evidence for this variant's role is considered robust, and it is the primary target for molecular genetic testing in populations where the condition is known to be more prevalent. While other rare mutations in the IKBKAP gene have been identified, the overwhelming majority of clinical cases in this specific ancestry are linked to this single founder mutation. Consequently, clinical guidelines often recommend targeted analysis for this variant as a first-line screening approach for individuals of Ashkenazi Jewish descent.

Population Frequency and Carrier Status

The prevalence of the rs111033171 variant is notably higher in the Ashkenazi Jewish population compared to the general global population. Epidemiological studies have estimated the carrier frequency for this specific mutation to be approximately 1 in 32 among individuals of Ashkenazi Jewish heritage. This frequency is comparable to that of other well-known genetic conditions within this community, such as Tay-Sachs disease and cystic fibrosis. Because the condition is inherited in an autosomal recessive manner, carriers of a single copy of the variant typically do not exhibit symptoms of familial dysautonomia. However, when two carriers have children, there is a 25% chance for each pregnancy that the child will inherit two copies of the variant and be affected by the condition. Due to these statistics, genetic counseling and carrier screening are widely available and encouraged for individuals of Ashkenazi Jewish descent who are planning to start a family.

Navigating Genetic Information

Understanding your genetic status regarding rs111033171 is a personal decision that can provide valuable information for family planning. If you receive results indicating you are a carrier, it simply means you possess one copy of the variant and are not affected by the condition yourself. This information is not a medical diagnosis and does not imply that you will develop health issues related to this gene. If you are concerned about your carrier status or have a family history of familial dysautonomia, the most appropriate step is to consult with a certified genetic counselor or a medical professional. They can help interpret your results in the context of your personal and family history, explain the implications for reproductive health, and discuss available testing options for partners. Never use genetic data to make independent medical decisions; always rely on the guidance of qualified healthcare providers who can offer personalized support and clinical context.

Frequently asked questions

Sources & further reading

Related variants in IKBKAP